Your session is about to expire
← Back to Search
Cardiac Rehabilitation for Post-COVID Syndrome (CARE BEAR-LC Trial)
CARE BEAR-LC Trial Summary
This trial is testing whether cardiac rehabilitation can help people with long-term symptoms from COVID-19, who have reduced exercise capacity and reduced heart rate response.
CARE BEAR-LC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCARE BEAR-LC Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CARE BEAR-LC Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I need home oxygen therapy for my chronic lung condition.I was diagnosed with acute myocarditis less than 3 months ago.I get significantly worse after physical activity, preventing me from participating in heart rehab.You have a low exercise capacity and your heart rate doesn't increase enough during a physical test. If it's hard to find enough people for the study, they may include individuals with slightly better exercise capacity.I've had a recent heart attack, bypass surgery, or been diagnosed with heart failure.I have had a confirmed case of COVID-19.I have had COVID-19 symptoms for more than 90 days.I am taking beta-blockers, calcium channel blockers, or ivabradine.I have a history of serious heart or lung conditions.I cannot ride a stationary bike for a fitness test.I have a heart rhythm problem that needs medication.I can attend 12 cardiac rehab sessions at UCSF Parnassus.I am 18 years old or older.You have a pacemaker or defibrillator implanted in your body.
- Group 1: Cardiac Rehabilitation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are new enrollees currently being considered for this research project?
"Accurate, clinicaltrials.gov has marked this medical trial as open for recruitment since December 1st 2022; the most recent alteration was on November 29th of that same year."
What is the aggregate figure of participants enrolled in this clinical trial?
"Affirmative. Clinicaltrials.gov has documentation of this ongoing medical study, which was initially posted on December 1st 2022 and revised at the end of November that same year. This trial is in search of 25 participants from one hospital or research site."
What is the prime purpose of this research endeavor?
"The stated goal of this medical trial is to measure the alteration in Peak VO2 (ml/kg/min) over a period of 12 weeks, beginning at Baseline. Secondary objectives include tracking changes in Composite Autonomic Symptom Scale-31 Score (0-100), Peak VO2 as a percentage predicted using Wasserman equations derived from cardiopulmonary testing, and attendance records for both physical and virtual Cardiac Rehabilitation sessions."
Share this study with friends
Copy Link
Messenger